These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3234485)

  • 21. Comparison of the effects of the K(+)-channel openers cromakalim and minoxidil sulphate on vascular smooth muscle.
    Wickenden AD; Grimwood S; Grant TL; Todd MH
    Br J Pharmacol; 1991 May; 103(1):1148-52. PubMed ID: 1878752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The action of a potassium channel activator, BRL 38227 (lemakalim), on human airway smooth muscle.
    Black JL; Armour CL; Johnson PR; Alouan LA; Barnes PJ
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 1):1384-9. PubMed ID: 2123615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cromakalim and lemakalim on slow waves and membrane currents in colonic smooth muscle.
    Post JM; Stevens RJ; Sanders KM; Hume JR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):C375-82. PubMed ID: 1996617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of delayed rectifier K(+)-current by levcromakalim in single intestinal smooth muscle cells: effects of cations and dependence on K(+)-flux.
    McHugh D; Beech DJ
    Br J Pharmacol; 1995 Jan; 114(2):391-9. PubMed ID: 7881739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological studies of loperamide, an anti-diarrheal agent. II. Effects on peristalsis of the small intestine and colon in guinea pigs (author's transl)].
    Sohji Y; Kawashima K; Shimizu M
    Nihon Yakurigaku Zasshi; 1978 Jan; 74(1):155-63. PubMed ID: 640534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potassium channel activation by cromakalim affects the slow wave type action potential of colonic smooth muscle.
    Farraway L; Huizinga JD
    J Pharmacol Exp Ther; 1991 Apr; 257(1):35-41. PubMed ID: 1902258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory action of the potassium channel opener BRL 38227 on agonist-stimulated phosphoinositide metabolism in bovine tracheal smooth muscle.
    Challiss RA; Patel N; Adams D; Arch JR
    Biochem Pharmacol; 1992 Jan; 43(1):17-20. PubMed ID: 1310405
    [No Abstract]   [Full Text] [Related]  

  • 28. The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes.
    Escande D; Thuringer D; Leguern S; Cavero I
    Biochem Biophys Res Commun; 1988 Jul; 154(2):620-5. PubMed ID: 2456760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
    Taylor SG; Arch JR; Bond J; Buckle DR; Shaw DJ; Taylor JF; Ward JS
    J Pharmacol Exp Ther; 1992 May; 261(2):429-37. PubMed ID: 1578358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phentolamine and structurally related compounds selectively antagonize the vascular actions of the K+ channel opener, cromromakalim.
    McPherson GA; Angus JA
    Br J Pharmacol; 1989 Jul; 97(3):941-9. PubMed ID: 2758244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the bronchodilator properties of Ro 31-6930, a novel potassium channel opener, in the guinea-pig.
    Paciorek PM; Cowlrick IS; Perkins RS; Taylor JC; Wilkinson GF; Waterfall JF
    Br J Pharmacol; 1990 Jun; 100(2):289-94. PubMed ID: 2379034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of the potassium channel activator cromakalim on human isolated bronchial smooth muscle].
    Luo Y; Liu J; Zhou L
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):149-51, 189. PubMed ID: 8565081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A potassium channel activator modulates both excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways.
    Ichinose M; Barnes PJ
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1207-12. PubMed ID: 2108238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of BRL 38227 on neurally-mediated responses in the guinea-pig isolated bronchus.
    Good DM; Clapham JC; Hamilton TC
    Br J Pharmacol; 1992 Apr; 105(4):933-40. PubMed ID: 1504720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional and species differences in glyburide-sensitive K+ channels in airway smooth muscles as estimated from actions of KC 128 and levcromakalim.
    Kamei K; Yoshida S; Imagawa J; Nabata H; Kuriyama H
    Br J Pharmacol; 1994 Nov; 113(3):889-97. PubMed ID: 7858882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cromakalim and pinacidil on 86Rb efflux from guinea pig urinary bladder smooth muscle.
    Trivedi S; Stetz S; Levin R; Li J; Kau S
    Pharmacology; 1994 Sep; 49(3):159-66. PubMed ID: 7972330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of K-channel openers on the contractility and electrical activity of antral circular muscle in guinea-pig stomach.
    Kim KW; Kim SJ; Jun JY
    J Smooth Muscle Res; 1993 Oct; 29(5):145. PubMed ID: 8167416
    [No Abstract]   [Full Text] [Related]  

  • 40. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
    Eltze M
    Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.